BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33039312)

  • 1. Characterization of Venezuelan Patients With Systemic Sclerosis: A Study in a Tertiary Hospital in Caracas.
    Rivas-Vargas D; Snih SA; Rodríguez MA
    Reumatol Clin (Engl Ed); 2020 Oct; ():. PubMed ID: 33039312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Venezuelan patients with systemic sclerosis: a study in a tertiary hospital in Caracas.
    Rivas-Vargas D; Snih SA; Rodríguez MA
    Reumatol Clin (Engl Ed); 2021 Dec; 17(10):601-606. PubMed ID: 34823828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Features, Autoantibody Profile, and Nailfold Capillaroscopy of Systemic Sclerosis: A Study of 60 Cases.
    Dave J; Mahajan S; Khadilkar P; Pradhan V
    J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.
    Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N
    Quant Imaging Med Surg; 2016 Aug; 6(4):381-390. PubMed ID: 27709074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters.
    Abdelati AA; Deghady AA; Abdelhady AM; Bastawy RA; Shaaban A
    Curr Rheumatol Rev; 2023; 19(2):189-196. PubMed ID: 35984025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
    Silva C; Solanki KK; White DHN
    Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor.
    Yu Q; Zhang J; Fan L; Yu T; Liu B; Ding J
    Discov Med; 2023 Apr; 35(175):193-200. PubMed ID: 37105929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center.
    Li H; Zhang X; Yu L; Shang J; Fan J; Feng X; Zhang R; Ren J; Guo Q; Duan X
    Front Med (Lausanne); 2022; 9():1061738. PubMed ID: 36561716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Manifestations in Systemic Sclerosis: Hospital-Based Descriptive Study.
    Mulkoju R; Saka VK; Rajaram M; Kumari R; Negi VS; Mohanty Mohapatra M; Govindaraj V; Dwivedi DP; Mahesh Babu V
    Cureus; 2020 Jun; 12(6):e8649. PubMed ID: 32685316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Interstitial Lung Disease in Patients with Systemic Sclerosis. A Pilot Study on the Role of Ultrasound.
    Reyes-Long S; Gutierrez M; Clavijo-Cornejo D; Alfaro-Rodríguez A; González-Sámano K; Cortes-Altamirano JL; Muñoz-Louis R; Cruz-Arenas E; Camargo K; Gonzalez F; Bertolazzi C
    Reumatol Clin (Engl Ed); 2021 Mar; 17(3):144-149. PubMed ID: 31400981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon.
    Park JS; Park MC; Song JJ; Park YB; Lee SK; Lee SW
    Arthritis Res Ther; 2015 Mar; 17(1):77. PubMed ID: 25889905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous and serologic subsets of systemic sclerosis.
    Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
    J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Manifestation and Incidence of Cardiopulmonary Complications in Early Systemic Sclerosis Patients with Different Antibody Profiles.
    Wangkaew S; Prasertwittayakij N; Euathrongchit J
    J Clin Med Res; 2019 Jul; 11(7):524-531. PubMed ID: 31236172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-carbamylated protein antibodies in systemic sclerosis.
    Liem SIE; Hoekstra EM; Levarht EWN; Dorjee AL; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK; Fehres CM
    Arthritis Res Ther; 2023 Jul; 25(1):123. PubMed ID: 37480150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of Anti-Topoisomerase-I, Anti-Th/To Antibody and Anti-Fibrillarin Using Immunoblot Method in Systemic Sclerosis Related Interstitial Lung Disease Patients.
    Logito V; Tjandrawati A; Sugianli AK; Tristina N; Dewi S
    Open Access Rheumatol; 2023; 15():43-49. PubMed ID: 37143703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.